GLP-3 Lets break down the key differences in a clear, comparative format: Primary Location of Action GLP-1: Pancreas, brain, stomach, cardiovascular system GLP-2: Intestinal tract, gut epithelium GLP-3: Unknown/under investigation Main Functions GLP-1: Regulates blood sugar Suppresses appetite Promotes weight loss Slows gastric emptying Protects cardiovascular system GLP-2: Promotes intestinal growth Enhances nutrient absorption Repairs gut lining Reduces inflammation Strengthens gut barrier GLP-3: Functions not well established Potentially metabolic or intestinal Requires more research Clinical Applications GLP-1: Type 2 diabetes treatment Obesity and weight management Cardiovascular disease prevention Potential neuroprotection GLP-2: Short bowel syndrome Inflammatory bowel disease (experimental) Intestinal injury recovery Malabsorption disorders GLP-3: No established clinical applications Currently research-only Half-Life GLP-1: Very short (2 minutes for natural form
L., Raggio, A
Both are low-density and both are Lilly, but they are different labs, and each labs native-GIP control differs Coskun reads native GIP at 0.574 nM, Willard at 0.888 nM, a 1.55 offset
Our bodies are constantly producing free radicals (uncharged, highly reactive molecules with unpaired electrons)
Dont Take Someone Elses Medication GLP-1 doses are individualized
This improves the patients quality of life